admin There have been positive signs from the researchers towards the production of the Wuhan coronavirus vaccine as they have taken significant steps in finding an immunization method.
Multiple research organizations around the globe and at least three pharmaceutical giants have been working towards finding an effective solution by taking different approaches. We have observed an increase in the efforts after the Chinese academics publicly posted the sequence of the virus.
Great news came from Maryland as a research team at eh National Institutes of Health (NIH) claimed to have produced a modified version of a key section of the virus to force the body to produce antibodies against the disease.
Along with NIH, there have been many other efforts throughout the world that have been made. The Coalition for Epidemic Preparedness Innovations (Cepi) has announced it would commit $11m to three programs led by the companies Inovio Pharmaceuticals and Moderna, and the University of Queensland, while hoping to have a viable vaccine working in 16 weeks, although the safety testing will take much more time than expected.
The lead researcher of the NIH coronavirus vaccine team, Kizzmekia Corbett, said that her team had been focusing on the spike proteins- the main part of the virus. This work is done on the already researched work during the severe acute respiratory syndrome (Sars) outbreak in 2001. Coronavirus is very similar to Sars virus. Corbett said, “Sars and the Wuhan coronavirus are similar across 82% of the entire genome. But from a vaccine point of view we were interested only in the spike, which is 70% identical.”
Magazine 
